ClinVar Miner

Submissions for variant NM_001035.3(RYR2):c.6829T>C (p.Cys2277Arg)

dbSNP: rs794727676
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000435115 SCV000230672 uncertain significance not provided 2014-09-09 criteria provided, single submitter clinical testing
GeneDx RCV000435115 SCV000530405 likely pathogenic not provided 2016-07-28 criteria provided, single submitter clinical testing The C2277R variant in the RYR2 gene has been reported previously in this family, where it was found to co-segregate with a CPVT phenotype in 7 of 8 heterozygous carriers; this family also had a history of sudden cardiac death in multiple individuals (Domingo et al., 2015). The C2277R variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The C2277R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, we interpret C2277R as a strong candidate for a pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.